Cilliers–Beighton syndrome

Cilliers–Beighton syndrome is a rare genetic disorder characterized by a combination of physical and developmental anomalies. It was first described by Cilliers and Beighton in the late 20th century, marking a significant contribution to the field of genetics and rare diseases. This syndrome is known for its distinct clinical features, including cardiac anomalies, skeletal dysplasia, and growth retardation, among others. The exact genetic cause of Cilliers–Beighton syndrome remains under investigation, but it is believed to involve mutations affecting developmental pathways.

Symptoms and Characteristics

Cilliers–Beighton syndrome presents a range of symptoms, varying significantly among affected individuals. Common characteristics include:

• Cardiac Anomalies: Congenital heart defects are frequently observed in patients, necessitating early and ongoing cardiac monitoring.
• Skeletal Dysplasia: Abnormal bone growth and development, leading to short stature and skeletal abnormalities.
• Growth Retardation: Affected individuals often exhibit delayed physical growth, falling below the average height and weight for their age group.
• Facial Dysmorphisms: Distinctive facial features may include a prominent forehead, widely spaced eyes (hypertelorism), and a small jaw (micrognathia).
• Intellectual Disability: Some individuals may experience varying degrees of intellectual disability or developmental delays.

Genetics

The genetic basis of Cilliers–Beighton syndrome is not fully understood, but it is believed to follow an autosomal recessive inheritance pattern. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the syndrome. Research is ongoing to identify the specific gene(s) involved and to understand the molecular mechanisms underlying the condition.

Diagnosis

Diagnosis of Cilliers–Beighton syndrome is primarily based on clinical evaluation and the presence of characteristic features. Genetic testing may be helpful in confirming the diagnosis, especially in cases where the clinical presentation is ambiguous. Early diagnosis is crucial for managing symptoms and improving the quality of life for affected individuals.

Treatment and Management

There is no cure for Cilliers–Beighton syndrome, and treatment is symptomatic and supportive. Management strategies may include:

• Cardiac Care: Regular monitoring and treatment of cardiac anomalies by a specialist.
• Orthopedic Support: Management of skeletal dysplasia and related complications, possibly including surgery.
• Growth Monitoring: Close monitoring of growth and development, with interventions as needed to support nutritional status and overall health.
• Educational Support: Tailored educational programs to address developmental delays or intellectual disabilities.

Prognosis

The prognosis for individuals with Cilliers–Beighton syndrome varies depending on the severity of symptoms and the presence of congenital heart defects. With appropriate medical and supportive care, many affected individuals can lead fulfilling lives.

See Also

• Genetic disorder
• Rare diseases
• Congenital heart defect
• Skeletal dysplasia

Cilliers–Beighton syndrome Resources
Latest articles Most recent articles Ongoing trials	Wikipedia